Bromocriptine Capsules and Insulin lispro Subcutaneous
Determining the interaction of Bromocriptine Capsules and Insulin lispro Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromocriptine
Brand name: Parlodel, Cycloset
Synonyms: Bromocriptine
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromocriptine Capsules-Insulin NPH
- Bromocriptine Capsules-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Bromocriptine Capsules-Insulin NPH (Vials)
- Bromocriptine Capsules-Insulin NPH and Insulin Regular
- Bromocriptine Capsules-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Bromocriptine Capsules-Insulin NPH and Insulin Regular (Vials)
- Insulin lispro Subcutaneous-Bromocriptine Mesylate
- Insulin lispro Subcutaneous-Brompheniramine
- Insulin lispro Subcutaneous-Brompheniramine and codeine
- Insulin lispro Subcutaneous-Brompheniramine and phenylephrine
- Insulin lispro Subcutaneous-Brompheniramine and Phenylephrine Chewable Tablets
- Insulin lispro Subcutaneous-Brompheniramine and Phenylephrine Liquid